Novo partners with Anthropic for AI drug discovery

Danish pharmaceutical company Novo has partnered with US technology company Anthropic.

The two companies will use artificial intelligence to speed up drug discovery.

Novo plans to use Anthropic's Claude Science AI model in its research.

This technology will help address central challenges in drug development.

The agreement is part of Novo's wider strategy to expand AI research capabilities.

This story was reported by The Copenhagen Post.